Australia markets closed

Keymed Biosciences Inc. (2162.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
36.000+0.400 (+1.12%)
At close: 04:08PM HKT
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in CNY. All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
851,029
604,070
1,520,619
199,409
Other short-term investments
1,868,157
2,571,256
2,003,960
154,673
Total cash
2,719,186
3,175,326
3,524,579
354,082
Net receivables
16,091
0
-
-
Inventory
56,354
44,495
16,393
6,846
Total current assets
2,939,531
3,309,974
3,581,949
380,917
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,019,772
653,677
341,777
150,163
Accumulated depreciation
-108,832
-57,212
-35,296
-24,016
Net property, plant and equipment
910,940
596,465
306,481
126,147
Intangible assets
5,234
1,496
1,104
109
Other long-term assets
-
15,841
-
-
Total non-current assets
943,391
622,342
352,506
149,028
Total assets
3,882,922
3,932,316
3,934,455
529,945
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
45,825
61,163
0
42,373
Accounts payable
29,488
14,913
2,784
3,418
Total current liabilities
314,180
379,699
112,075
80,240
Non-current liabilities
Long-term debt
331,834
28,800
0
-
Deferred tax liabilities
278
0
-
-
Deferred revenues
228,194
163,671
8,719
6,786
Total non-current liabilities
581,929
213,399
176,998
1,544,508
Total liabilities
896,109
593,098
289,073
1,624,748
Stockholders' equity
Common stock
169
170
171
45
Retained earnings
-5,649,364
-5,290,007
3,650,799
-1,094,583
Total stockholders' equity
2,986,311
3,340,288
3,650,970
-1,094,538
Total liabilities and stockholders' equity
3,882,922
3,932,316
3,934,455
529,945